Keynote Presentations

Coordinated Oscillations in Cortical Actin and Ca(2+) Correlate with Cycles of Vesicle Secretion

Roy Wollman, Ph.D., Assistant Professor, Chemistry and Biochemistry, University of California San Diego

Higher-Faster-Further: Why It Makes Sense to Invest in Innovation to Achieve Disruptive Improvements

Torsten W. Schulz, Ph.D., Director, Cell Culture, Boehringer Ingelheim Fremont, Inc.

Featured Presentations

Stable Depletion of miR-7 Expression for Improved Performance of a CHO Batch-Fed Culture

Niall Baron, Ph.D., Senior Research Scientist, National Institute for Cellular Biotechnology, Dublin City University, Ireland

Technology Toolbox for Cell Line Development - Towards High Speed, Yield and Clonal Stability

Thomas Jostock, Ph.D., Novartis Leading Scientist, Novartis Pharma AG, Switzerland

Special Discounted Hotel Rate

Special Discounted Hotel Rate Available Until April 19, 2013. To book your room, call 402-592-6464 or 1-888-421-1442 and mention that you are an IBC attendee at this event.

New to the Field?

Consider Attending IBC's Two-Day Intensive Training Course:
Cell Culture and Fermentation Bioprocessing (separate registration required)

East and West Coast Locations:

• May 14-15, 2013 in San Diego, CA
• June 12-13, 2013 in Cambridge, MA

» Full course details

Get Up To Date Event Information

Join our priority contact list and receive the latest event news.

Gain Perspectives from Exclusive Case Studies and Unpublished Data to Help You -

• Develop a Custom Cell Line Toolbox with Diverse Product Quality Attributes
• Utilize Molecular Assessment Programs to Balance Upstream Work with Downstream Payoffs
• Apply Next Generation Sequencing Technologies in Biomanufacturing
• Integrate Multiple Omics Data Sets to Understand Growth Rate Regulation in CHO
• Overcome Cell Line and Process Development Challenges for Biosimilars
• Incorporate High Throughput Imaging to Increase the Assurance of Clonality

"Quite worthwhile! Informative, encompassing, broad and yet relevant topics. Great venue for discussion and interaction." - Lynn Davis, Ph.D., Senior Research Biologist, Bend Research Inc.

Join Industry Leaders at Cell Line Development & Engineering

IBC's Cell Line Development & Engineering conference is driven by the novel approaches and emerging tools that are designed to save you time and money during the process of selecting, developing and engineering your cell lines.

In 3 information packed days, you hear experiences, successes and lessons learned from companies utilizing the rapidly expanding technology toolbox to dramatically improve the speed of cell line development, minimize risk, and increase process and product quality.

"By narrowly targeting the technologies used at the border of R&D of biotherapeutics, this event provides an intensive 3-day review of current, valuable information for this highly specialized group." - Pam Hawley-Nelson, Ph.D., Associate Director, Process Cell Culture, MedImmune

Industry leaders and world-renowned academics share exclusive case studies and unpublished data, providing you with the information required to overcome your toughest challenges and help your company achieve:

• The promise of 'omics technologies in process development
• High production stability with targeted integration
• Improved cell density and prolonged viability with stable depletion of miR-7
• Lead candidates with optimal stability, productivity, safety and delivery characteristics from early developability assessments
• Improved collaboration at the interface of development and discovery
• Better understanding of gene expression regulation with next generation sequencing
• Big timeline reductions through engineering of host cell line and expression vector
• In process control of glycosylation during high yield production

"This is an outstanding venue for bringing together experts in the field, vendors, scientists and other interested parties, and the collaborative and open environment has always been rewarding. This meeting is on my calendar every year!" - Gene Lee, Ph.D., Director, Protein and Cell Sciences, EMD Serono